Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 59, Issue 2, Pages 357-362
Publisher
Informa UK Limited
Online
2017-06-09
DOI
10.1080/10428194.2017.1330954
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma
- (2014) Jason R. Westin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Sensitizing B- and T- cell Lymphoma Cells to Paclitaxel/Abraxane–Induced Death by AS101 via Inhibition of the VLA-4–IL10–Survivin Axis
- (2014) Hila Danoch et al. MOLECULAR CANCER RESEARCH
- SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients
- (2014) Neil Desai et al. Translational Oncology
- Vinorelbine, Paclitaxel, Etoposide, Cisplatin, and Cytarabine (VTEPA) Is an Effective Second Salvage Therapy for Relapsed/Refractory Hodgkin Lymphoma
- (2013) Rajni Sinha et al. Clinical Lymphoma Myeloma & Leukemia
- Combination of albumin-bound paclitaxel and pegylated liposomal doxorubicin is effective in treatment of heavily treated relapsed/refractory diffuse large B-cell lymphoma: a case report
- (2013) Liang Wang et al. LEUKEMIA & LYMPHOMA
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weeklynab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
- (2012) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes
- (2011) P. P. Piccaluga et al. BLOOD
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Response to nab-Paclitaxel Compared with Cremophor-Solubilized Paclitaxel is Independent of Secreted Protein Acidic and Rich in Cysteine Expression in Non-Small Cell Lung Cancer
- (2011) Huanjie Shao et al. Journal of Thoracic Oncology
- The Stromal Cell Marker SPARC Predicts for Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab
- (2010) Paul N. Meyer et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma
- (2010) Chun-Te Chiang et al. CANCER LETTERS
- Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and nab-Paclitaxel
- (2008) E. R. Gardner et al. CLINICAL CANCER RESEARCH
- SPARC in cancer biology: Its role in cancer progression and potential for therapy
- (2008) Isabella T. Tai et al. DRUG RESISTANCE UPDATES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now